E. coli Secretome Metabolically Modulates MDA-MB-231 Breast Cancer Cells’ Energy Metabolism

Abstract

Breast cancer (BC) is commonly diagnosed in women. BC cells are associated with altered metabolism, which is essential to support their energetic requirements, cellular proliferation, and continuous survival. The altered metabolism of BC cells is a result of the genetic abnormalities of BC cells. Risk factors can also enhance it, including age, lifestyle, hormone disturbances, etc. Other unknown BC-promoting risk factors are under scientific investigation. One of these investigated factors is the microbiome. However, whether the breast microbiome found in the BC tissue microenvironment can impact BC cells has not been studied. We hypothesized that E. coli, part of a normal breast microbiome with more presence in BC tissue, secretes metabolic molecules that could alter BC cells’ metabolism to maintain their survival. Thus, we directly examined the impact of the E. coli secretome on the metabolism of BC cells in vitro. MDA-MB-231 cells, an in vitro model of aggressive triple-negative BC cells, were treated with the E. coli secretome at different time points, followed by untargeted metabolomics analyses via liquid chromatography–mass spectrometry to identify metabolic alterations in the treated BC cell lines. MDA-MB-231 cells that were not treated were used as controls. Moreover, metabolomic analyses were performed on the E. coli secretome to profile the most significant bacterial metabolites affecting the metabolism of the treated BC cell lines. The metabolomics results revealed about 15 metabolites that potentially have indirect roles in cancer metabolism that were secreted from E. coli in the culture media of MDA-MB-231 cells. The cells treated with the E. coli secretome showed 105 dysregulated cellular metabolites compared to controls. The dysregulated cellular metabolites were involved in the metabolism of fructose and mannose, sphingolipids, amino acids, fatty acids, amino sugar, nucleotide sugar, and pyrimidine, which are vital pathways required for the pathogenesis of BC. Our findings are the first to show that the E. coli secretome modulates the BC cells’ energy metabolism, highlighting insights into the possibility of altered metabolic events in BC tissue in the actual BC tissue microenvironment that are potentially induced by the local bacteria. Our study provides metabolic data that could be as a basis for future studies searching for the underlying mechanisms mediated by bacteria and their secretome to alter the metabolism of BC cells.

Exploratory Untargeted Metabolomics of Dried Blood Spot Samples from Newborns with Maple Syrup Urine Disease

“…Quality control samples (QCs) were performed gently by collecting a single 3.2 mm punch from each study sample and pooling them for extraction. After that, they were introduced to the instrument randomly to validate the system’s stability [ 58 ]. After that, they were analyzed following the routine protocol.…”

Metabolic Alteration of MCF-7 Cells upon Indirect Exposure to E. coli Secretome: A Model of Studying the Microbiota Effect on Human Breast Tissue

“…To investigate the metabolic alterations occurring in our cell model, we followed a previously reported protocol to extract intra- and extracellular metabolites [ 10 ]. Briefly, in intracellular metabolism, medium was removed, and cells were washed with cold PBS followed by quenching in liquid nitrogen.…”

“…The samples were reconstituted in 50% mobile phase A:B (A: 0.1% formic acid in dH 2 O, B: 0.1% formic acid in 50% MeOH and ACN) for untargeted metabolomics analyses using LCMS as previously reported [ 10 ]. Metabolites were acquired by a Waters Acquity ultra pressure liquid chromatography (UPLC) system coupled with a Xevo G2-S QTOF mass spectrometer equipped with an electrospray ionization source (ESI) on positive and negative (ESI+, ESI−).…”

“…We have shown recently that the Escherichia coli ( E. coli ) secretome linked to breast inflammation and cancer development affects significant metabolic processes, including fructose and mannose, sphingolipids, amino acids, fatty acids, amino sugar, nucleotide sugar, and pyrimidine [ 10 ].…”

Metabolomic Profiling of Blood Plasma in Females with Hyperplasia and Endometrial Cancer

“…Metabolomics profiling was performed using untargeted metabolomics analyses by LC-HRMS, as previously reported [22]. Metabolites were acquired by a Waters ACQUITY ultrahigh-pressure liquid chromatography (UPLC) system coupled with a Xevo G2-S QTOF mass spectrometer equipped with an electrospray ionization source (ESI) in positive and negative modes (ESI+, ESI−).…”